| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium channel activity | 2.37e-04 | 129 | 19 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 3.19e-04 | 28 | 19 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.76e-04 | 151 | 19 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.52e-04 | 465 | 19 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.56e-03 | 627 | 19 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 3.15e-03 | 664 | 19 | 4 | GO:0008324 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.97e-03 | 343 | 19 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.06e-03 | 758 | 19 | 4 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 5.94e-03 | 793 | 19 | 4 | GO:0015075 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 8.89e-03 | 459 | 19 | 3 | GO:0005216 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 1.20e-05 | 6 | 19 | 2 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 1.20e-05 | 6 | 19 | 2 | GO:0018103 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 1.20e-05 | 6 | 19 | 2 | GO:0018317 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 1.20e-05 | 6 | 19 | 2 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein mannosylation | 2.38e-04 | 25 | 19 | 2 | GO:0035268 | |
| GeneOntologyBiologicalProcess | mannosylation | 2.58e-04 | 26 | 19 | 2 | GO:0097502 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.86e-04 | 142 | 19 | 3 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.86e-04 | 142 | 19 | 3 | GO:0099587 | |
| GeneOntologyBiologicalProcess | molting cycle | 3.35e-04 | 150 | 19 | 3 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 3.35e-04 | 150 | 19 | 3 | GO:0042633 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 8.84e-04 | 48 | 19 | 2 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 8.84e-04 | 48 | 19 | 2 | GO:1902656 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.16e-03 | 230 | 19 | 3 | GO:0098739 | |
| GeneOntologyBiologicalProcess | homologous chromosome pairing at meiosis | 1.38e-03 | 60 | 19 | 2 | GO:0007129 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 1.51e-03 | 252 | 19 | 3 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 1.51e-03 | 252 | 19 | 3 | GO:0006486 | |
| GeneOntologyBiologicalProcess | spermatid development | 1.69e-03 | 262 | 19 | 3 | GO:0007286 | |
| GeneOntologyBiologicalProcess | glycosylation | 1.84e-03 | 270 | 19 | 3 | GO:0070085 | |
| GeneOntologyBiologicalProcess | spermatid differentiation | 1.88e-03 | 272 | 19 | 3 | GO:0048515 | |
| GeneOntologyBiologicalProcess | chromosome organization involved in meiotic cell cycle | 2.14e-03 | 75 | 19 | 2 | GO:0070192 | |
| GeneOntologyBiologicalProcess | homologous chromosome segregation | 2.32e-03 | 78 | 19 | 2 | GO:0045143 | |
| MousePheno | abnormal sperm individualization | 8.34e-06 | 4 | 17 | 2 | MP:0031372 | |
| MousePheno | multiflagellated sperm | 1.26e-04 | 14 | 17 | 2 | MP:0009839 | |
| MousePheno | elongated manchette | 1.87e-04 | 17 | 17 | 2 | MP:0031386 | |
| MousePheno | ectopic manchette | 2.35e-04 | 19 | 17 | 2 | MP:0009377 | |
| MousePheno | increased thermal nociceptive threshold | 2.82e-04 | 108 | 17 | 3 | MP:0001973 | |
| Domain | TRPV1-4_channel | 5.26e-06 | 4 | 18 | 2 | IPR008347 | |
| Domain | TRP_channel | 4.80e-05 | 11 | 18 | 2 | IPR004729 | |
| Domain | Ion_trans_dom | 1.69e-04 | 114 | 18 | 3 | IPR005821 | |
| Domain | Ion_trans | 1.69e-04 | 114 | 18 | 3 | PF00520 | |
| Domain | Ank_2 | 1.08e-03 | 215 | 18 | 3 | PF12796 | |
| Domain | Ank | 1.28e-03 | 228 | 18 | 3 | PF00023 | |
| Domain | - | 1.63e-03 | 248 | 18 | 3 | 1.25.40.20 | |
| Domain | ANK | 1.69e-03 | 251 | 18 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 1.72e-03 | 253 | 18 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.74e-03 | 254 | 18 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.74e-03 | 254 | 18 | 3 | PS50297 | |
| Domain | Ankyrin_rpt | 1.91e-03 | 262 | 18 | 3 | IPR002110 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.53e-06 | 28 | 12 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.53e-06 | 28 | 12 | 3 | M27241 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 7.06e-05 | 99 | 12 | 3 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.65e-05 | 106 | 12 | 3 | M27200 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.87e-04 | 176 | 12 | 3 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.34e-04 | 183 | 12 | 3 | M997 | |
| Pubmed | 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. | 1.38e-09 | 5 | 19 | 3 | 15194687 | |
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 2.78e-07 | 24 | 19 | 3 | 33884443 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 24925072 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 22764053 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 26843581 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 25354700 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 25354701 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 22162417 | ||
| Pubmed | 3.15e-07 | 25 | 19 | 3 | 16382100 | ||
| Pubmed | 4.01e-07 | 27 | 19 | 3 | 16460286 | ||
| Pubmed | 7.46e-07 | 33 | 19 | 3 | 19834762 | ||
| Pubmed | Loss of interneuron LTD and attenuated pyramidal cell LTP in Trpv1 and Trpv3 KO mice. | 8.48e-07 | 3 | 19 | 2 | 23536486 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 12016205 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 25775128 | ||
| Pubmed | Duplication and relocation of the functional DPY19L2 gene within low copy repeats. | 8.48e-07 | 3 | 19 | 2 | 16526957 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 28905239 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 35666427 | ||
| Pubmed | Disruption of TRPV3 Impairs Heat-Evoked Vasodilation and Thermoregulation: A Critical Role of CGRP. | 8.48e-07 | 3 | 19 | 2 | 29054601 | |
| Pubmed | The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4⁺ T cells. | 8.48e-07 | 3 | 19 | 2 | 25282159 | |
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 19839244 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 17521436 | ||
| Pubmed | Nicotinic acid is a common regulator of heat-sensing TRPV1-4 ion channels. | 1.70e-06 | 4 | 19 | 2 | 25752528 | |
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 18983665 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 25333484 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 18787888 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 22566504 | ||
| Pubmed | 1.80e-06 | 44 | 19 | 3 | 19322198 | ||
| Pubmed | TRPV3 is a temperature-sensitive vanilloid receptor-like protein. | 2.82e-06 | 5 | 19 | 2 | 12077606 | |
| Pubmed | Role and regulation of TRP channels in neutrophil granulocytes. | 2.82e-06 | 5 | 19 | 2 | 12765698 | |
| Pubmed | FAM209 associates with DPY19L2, and is required for sperm acrosome biogenesis and fertility in mice. | 2.82e-06 | 5 | 19 | 2 | 34471926 | |
| Pubmed | Involvement of TRPM2 and TRPM8 in temperature-dependent masking behavior. | 2.82e-06 | 5 | 19 | 2 | 30842533 | |
| Pubmed | 5.93e-06 | 7 | 19 | 2 | 18701070 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 7.02e-06 | 1451 | 19 | 7 | 30550785 | |
| Pubmed | 1.02e-05 | 9 | 19 | 2 | 17480026 | ||
| Pubmed | 1.13e-05 | 263 | 19 | 4 | 34702444 | ||
| Pubmed | Deficiency of TRPM2 leads to embryonic neurogenesis defects in hyperthermia. | 4.30e-05 | 18 | 19 | 2 | 31911949 | |
| Pubmed | 5.34e-05 | 20 | 19 | 2 | 22028030 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 9.75e-05 | 457 | 19 | 4 | 32344865 | |
| Pubmed | 1.48e-04 | 33 | 19 | 2 | 30037926 | ||
| Pubmed | Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. | 1.96e-04 | 38 | 19 | 2 | 16263699 | |
| Cytoband | 17p13.2 | 2.38e-04 | 55 | 19 | 2 | 17p13.2 | |
| GeneFamily | Transient receptor potential cation channels | 9.42e-07 | 28 | 13 | 3 | 249 | |
| GeneFamily | Ankyrin repeat domain containing | 1.26e-02 | 242 | 13 | 2 | 403 | |
| ToppCell | severe-Others-CD34+_GATA2+_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.96e-07 | 179 | 19 | 4 | dd789a1b7327d6f9ed5272f3eb54bd43f7ae8d78 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.1500015O10Rik_(1500015O10Rik)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.49e-05 | 114 | 19 | 3 | c3feca81edee445cbe5e46a07e1a59327dc2e981 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.1500015O10Rik_(1500015O10Rik)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.49e-05 | 114 | 19 | 3 | 89350483d2ce57afc612fe25398e35af121d50f0 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-05 | 164 | 19 | 3 | eae6d440877b292ad18dc4bd02802dda5b2f9c60 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.54e-05 | 177 | 19 | 3 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.73e-05 | 179 | 19 | 3 | be1e09145e24cd40ba51aae1fcd868b4c1e2b4c1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-05 | 180 | 19 | 3 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 6.31e-05 | 185 | 19 | 3 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.83e-05 | 190 | 19 | 3 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.05e-05 | 192 | 19 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.38e-05 | 195 | 19 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.38e-05 | 195 | 19 | 3 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.38e-05 | 195 | 19 | 3 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.61e-05 | 197 | 19 | 3 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.61e-05 | 197 | 19 | 3 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 7.61e-05 | 197 | 19 | 3 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.72e-05 | 198 | 19 | 3 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.72e-05 | 198 | 19 | 3 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.72e-05 | 198 | 19 | 3 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 7.72e-05 | 198 | 19 | 3 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 7.84e-05 | 199 | 19 | 3 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.96e-05 | 200 | 19 | 3 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.96e-05 | 200 | 19 | 3 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Th_(eccentric_SPN,_iSPN-like_markers,_Th+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.79e-04 | 68 | 19 | 2 | 761bb83d0fe2817b8fffe1fea6fe738d8107bbbd | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a-Excitatory_Neuron.Gad1Gad2.Adora2a-Th_(eccentric_SPN,_iSPN-like_markers,_Th+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.79e-04 | 68 | 19 | 2 | 10895359ba0a3598edbf27a202e4232bfa483ec1 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 77 | 19 | 2 | ebb1a537751739232820a60f88911877fc683855 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-04 | 88 | 19 | 2 | 1ca0e16981e88030987412e12838a9797b97b9c9 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp-Endothelial_Tip.Dcn.Mgp-Clu_(Clu)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.52e-04 | 96 | 19 | 2 | 9a1da3809073a4321134bf3767e0a40398b69caa | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.16e-04 | 100 | 19 | 2 | cb0deaf1c33d2789417e93cc01d94e34a611d20a | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.16e-04 | 106 | 19 | 2 | a6334b67be05f78145b57271b7959471b80bd67f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.16e-04 | 106 | 19 | 2 | 7079111add27d7b3411dfe739280d62dc256a174 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 113 | 19 | 2 | 7e24c0f6a80e10a2a41325d48a87628bd330a1e2 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 113 | 19 | 2 | c0b8d7a2e3722029e850051bdff77f31f34a8cca | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.04e-03 | 113 | 19 | 2 | fed408864201218295bac0cc6647953fda8d688e | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 115 | 19 | 2 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 115 | 19 | 2 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 115 | 19 | 2 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.25e-03 | 124 | 19 | 2 | b0ed84522180f8cea541461faf7882c57abf8cd4 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.25e-03 | 124 | 19 | 2 | 231862f849d8ab73c6a44c782d33ef2f07661baf | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 130 | 19 | 2 | 3b6a8eaef593db73c2fad2260b9f1e15950ccb70 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 130 | 19 | 2 | 3041d20fe964d282d95c0312396f26bc93929056 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 130 | 19 | 2 | 8c81853c806e9a0d562e00dc5e00a8fc569a854c | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.48e-03 | 135 | 19 | 2 | 4451c44f3ad788437f4e2ae81049fbbab53f967e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.48e-03 | 135 | 19 | 2 | 45f67f33c8320d9fb6dbceae603b564f6a8ffd1e | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.48e-03 | 135 | 19 | 2 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-03 | 137 | 19 | 2 | 81cdb216e6c81acf9c2072f9d39e1a42612e1258 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-2|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.70e-03 | 145 | 19 | 2 | f9aa7f2401e26f1e8cec1112a71c16e1c2784893 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-03 | 146 | 19 | 2 | deeb2c90a478deac7805e1f0d1466bf5bc42f746 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.75e-03 | 147 | 19 | 2 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-03 | 152 | 19 | 2 | acfafdb64bd5b0eb7371b04cfef51ed2798e9b30 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-03 | 152 | 19 | 2 | 9d6c88ceca0569dbeb12e488acec7fcb7f972f03 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.87e-03 | 152 | 19 | 2 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 153 | 19 | 2 | 151c469b26f9adf04dd6f117f03bef760cc3d45d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-03 | 153 | 19 | 2 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-03 | 154 | 19 | 2 | cd99428c282d566b5dbd31fd5a0371b7ffe9ffa2 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 1.92e-03 | 154 | 19 | 2 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.97e-03 | 156 | 19 | 2 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-03 | 157 | 19 | 2 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.01e-03 | 158 | 19 | 2 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-03 | 159 | 19 | 2 | 50d951cf27a571c0c5002003c16fbc370fa17eb1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-03 | 160 | 19 | 2 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 162 | 19 | 2 | bc63a96ad3ba0b3433e3679d7a005f47709ff384 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-03 | 162 | 19 | 2 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.14e-03 | 163 | 19 | 2 | ec8336b68c8369e27d507c04c827be07bb48a7f6 | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 2.17e-03 | 164 | 19 | 2 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.19e-03 | 165 | 19 | 2 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.19e-03 | 165 | 19 | 2 | 6e8370b8e747d8ef44a2413a993291a3cd83a77c | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.22e-03 | 166 | 19 | 2 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | Influenza_Severe-cDC|Influenza_Severe / Disease group and Cell class | 2.22e-03 | 166 | 19 | 2 | b40bdf0f7f381e25be61188e9f6c294d25a8b824 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.22e-03 | 166 | 19 | 2 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-03 | 167 | 19 | 2 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-03 | 167 | 19 | 2 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-03 | 167 | 19 | 2 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-03 | 168 | 19 | 2 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-03 | 168 | 19 | 2 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 2.27e-03 | 168 | 19 | 2 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-03 | 168 | 19 | 2 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.27e-03 | 168 | 19 | 2 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.27e-03 | 168 | 19 | 2 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 2.30e-03 | 169 | 19 | 2 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-03 | 169 | 19 | 2 | e68e6c24606fd46eca6f86bb63fa86ea17879ae2 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 170 | 19 | 2 | ca88dc0b7a6960facb7c4d3c0f4795431a0a43d2 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-03 | 170 | 19 | 2 | 52fdf93c2803fecb2a640ef4e0b257786f3d4cb1 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.33e-03 | 170 | 19 | 2 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-03 | 170 | 19 | 2 | 263e98aa1c49493cc262b2608c6582930841cb10 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 170 | 19 | 2 | b6882665a27c78a63f3b4a2a8806c8438a98e407 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 170 | 19 | 2 | 626c12b9a51218f72ee32afb5fd5d4b075025d75 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-03 | 170 | 19 | 2 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-03 | 170 | 19 | 2 | 31daac8696ae8c021c0302d3b30dd8194054b3e7 | |
| ToppCell | COVID-19_Convalescent-cDC|COVID-19_Convalescent / Disease condition and Cell class | 2.35e-03 | 171 | 19 | 2 | 9ccaa9f1629818b0f63a5d930ee78c01e04cd98d | |
| ToppCell | COVID-19_Convalescent-cDC-|COVID-19_Convalescent / Disease condition and Cell class | 2.35e-03 | 171 | 19 | 2 | fb5fae8b3adafcbb7c5618d887966b418355ed4d | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.35e-03 | 171 | 19 | 2 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.38e-03 | 172 | 19 | 2 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-03 | 172 | 19 | 2 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-03 | 172 | 19 | 2 | 107417cfab7775bc1f80807115047abfb50b7a7e | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 2.38e-03 | 172 | 19 | 2 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.41e-03 | 173 | 19 | 2 | 6989c9cebcd81eccceac7e5a86152676ee959386 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.41e-03 | 173 | 19 | 2 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.41e-03 | 173 | 19 | 2 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.44e-03 | 174 | 19 | 2 | 66df78280f657978c4a568010ae7d7943869af90 | |
| Drug | PPAHV | 6.59e-06 | 5 | 19 | 2 | CID003035862 | |
| Drug | drimanial | 9.88e-06 | 6 | 19 | 2 | CID000636975 | |
| Drug | isovelleral | 1.38e-05 | 7 | 19 | 2 | CID000037839 | |
| Drug | CID5148062 | 4.33e-05 | 12 | 19 | 2 | CID005148062 | |
| Drug | tinyatoxin | 5.97e-05 | 14 | 19 | 2 | CID000005481 | |
| Drug | Camphor | 5.97e-05 | 14 | 19 | 2 | ctd:D002164 | |
| Drug | polygodial | 5.97e-05 | 14 | 19 | 2 | CID000072503 | |
| Drug | 1-oleoyl-2-acetylglycerol | 6.88e-05 | 15 | 19 | 2 | ctd:C038237 | |
| Drug | borate | 7.13e-05 | 98 | 19 | 3 | CID000007628 | |
| Drug | bosentan | 9.00e-05 | 106 | 19 | 3 | CID000104865 | |
| Drug | resiniferonol | 1.00e-04 | 18 | 19 | 2 | CID000162824 | |
| Drug | zingerone | 1.12e-04 | 19 | 19 | 2 | CID000031211 | |
| Drug | phorbol-12,13-dibenzoate | 1.24e-04 | 20 | 19 | 2 | CID000072294 | |
| Drug | Diglycerides | 1.24e-04 | 20 | 19 | 2 | ctd:D004075 | |
| Drug | Ouabain | 1.27e-04 | 119 | 19 | 3 | ctd:D010042 | |
| Drug | AC1NS1PP | 1.37e-04 | 21 | 19 | 2 | CID005327132 | |
| Drug | noladin ether | 1.37e-04 | 21 | 19 | 2 | CID006483057 | |
| Drug | Ruthenium Red | 1.65e-04 | 23 | 19 | 2 | ctd:D012430 | |
| Drug | AC1L28IG | 1.80e-04 | 24 | 19 | 2 | CID000042760 | |
| Drug | rac Lafutidine | 1.96e-04 | 25 | 19 | 2 | CID000003873 | |
| Drug | Virginiamycin S1 | 2.46e-04 | 28 | 19 | 2 | CID000122731 | |
| Drug | NSC 255317 | 2.83e-04 | 30 | 19 | 2 | CID000099644 | |
| Drug | Fura Red | 2.83e-04 | 30 | 19 | 2 | CID006438360 | |
| Drug | N-arachidonoyl-dopamine | 4.80e-04 | 39 | 19 | 2 | CID005282105 | |
| Drug | C09179 | 4.80e-04 | 39 | 19 | 2 | CID000442082 | |
| Drug | gadolinium | 5.75e-04 | 199 | 19 | 3 | CID000023982 | |
| Drug | cannabidiol | 5.84e-04 | 43 | 19 | 2 | CID000026346 | |
| Drug | palmitoylethanolamide | 6.11e-04 | 44 | 19 | 2 | CID000004671 | |
| Drug | elaidamide | 7.58e-04 | 49 | 19 | 2 | CID000001930 | |
| Drug | AC1L1G0K | 7.58e-04 | 49 | 19 | 2 | CID000003473 | |
| Drug | Camphor | 8.53e-04 | 52 | 19 | 2 | CID000002537 | |
| Drug | R1-methanandamide | 8.86e-04 | 53 | 19 | 2 | CID000001293 | |
| Drug | AC1L1KC5 | 9.20e-04 | 541 | 19 | 4 | CID000005428 | |
| Drug | dithiobis(succinimidyl propionate | 1.02e-03 | 57 | 19 | 2 | CID000093313 | |
| Drug | SR 48968 | 1.06e-03 | 58 | 19 | 2 | CID000104974 | |
| Drug | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 1.13e-03 | 60 | 19 | 2 | ctd:C060229 | |
| Drug | 2-aminoethoxydiphenyl borate | 1.17e-03 | 61 | 19 | 2 | ctd:C109986 | |
| Drug | Russian VX | 1.21e-03 | 62 | 19 | 2 | CID000178033 | |
| Drug | C17H19NO3 | 1.25e-03 | 63 | 19 | 2 | CID000004840 | |
| Drug | resiniferatoxin | 1.37e-03 | 66 | 19 | 2 | CID000104826 | |
| Drug | AC1NSK22 | 1.37e-03 | 66 | 19 | 2 | CID005311131 | |
| Drug | Lopac-P-178 | 1.41e-03 | 67 | 19 | 2 | CID005478935 | |
| Drug | RP 54476 | 1.41e-03 | 67 | 19 | 2 | CID000005366 | |
| Drug | Neuromedin L. | 1.50e-03 | 69 | 19 | 2 | CID000055582 | |
| Drug | SR144528 | 1.54e-03 | 70 | 19 | 2 | CID003081355 | |
| Drug | AM251 | 1.54e-03 | 70 | 19 | 2 | CID000002125 | |
| Drug | 4 alpha-phorbol 12,13-didecanoate | 1.54e-03 | 70 | 19 | 2 | CID000452543 | |
| Drug | evodiamine | 1.67e-03 | 73 | 19 | 2 | CID000151289 | |
| Drug | Amiloride | 1.91e-03 | 78 | 19 | 2 | ctd:D000584 | |
| Disease | breast cancer, ovarian carcinoma | 2.58e-04 | 37 | 19 | 2 | EFO_0001075, MONDO_0007254 | |
| Disease | ovarian serous carcinoma | 4.00e-04 | 46 | 19 | 2 | EFO_1001516 | |
| Disease | myocardial infarction (implicated_via_orthology) | 8.22e-04 | 66 | 19 | 2 | DOID:5844 (implicated_via_orthology) | |
| Disease | age-related hearing impairment | 1.12e-03 | 324 | 19 | 3 | EFO_0005782 | |
| Disease | otosclerosis | 1.23e-03 | 81 | 19 | 2 | EFO_0004213 | |
| Disease | cancer | 2.04e-03 | 400 | 19 | 3 | MONDO_0004992 | |
| Disease | lower face morphology measurement | 2.22e-03 | 109 | 19 | 2 | EFO_0010948 | |
| Disease | cutaneous melanoma | 2.72e-03 | 121 | 19 | 2 | EFO_0000389 | |
| Disease | velopharyngeal dysfunction | 2.77e-03 | 122 | 19 | 2 | EFO_0009336 | |
| Disease | mean platelet volume | 3.63e-03 | 1020 | 19 | 4 | EFO_0004584 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTYDMFYMSQYGLYN | 781 | Q6ZN30 | |
| AFMYYMNDGVYGSFA | 311 | O14977 | |
| GTIMFYKGFLAYYQA | 126 | P00736 | |
| YPAFFGYYFFNSMMG | 296 | Q96G23 | |
| GYYFFNSMMGVLQLL | 301 | Q96G23 | |
| SMYQSYGSPSQYGMA | 106 | Q96PV6 | |
| FYGNIIYMYMQPGAS | 251 | Q7Z3T1 | |
| LMFGNSMYLSSYYSS | 386 | Q6NUT2 | |
| YPYYASAFSMMLGLF | 426 | P39656 | |
| LYNTGYYLGMFMNSF | 616 | Q6YHK3 | |
| GVLLQYYGMTEMNYY | 406 | O75390 | |
| YYGMTEMNYYTVLFG | 411 | O75390 | |
| SYFLMLIFMTYNGYL | 146 | O15431 | |
| LMFGNSMYLSSYYSS | 196 | Q6ZN68 | |
| SHLYPYFNMMYGDNS | 716 | A2RUB1 | |
| YALMGGYFMNVLVNF | 191 | Q9NX52 | |
| NMLYYTRGFQQMGIY | 551 | Q8NER1 | |
| AYGNMGNAYNALGMY | 516 | Q96AY4 | |
| NMLYYTRGFQSMGMY | 561 | Q8NET8 | |
| GMFNLYSYYIGAKQN | 651 | Q9Y210 | |
| MGYSYSLLYFVNNMN | 176 | Q9BTX1 |